Shunji Takahashi Selected Research

Shunji Takahashi Research Topics

Disease

105	Neoplasms (Cancer) 04/2024 - 12/2002
69	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2003
30	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 01/2015
30	Neoplasm Metastasis (Metastasis) 09/2023 - 12/2002
21	Thyroid Neoplasms (Thyroid Cancer) 04/2024 - 12/2015
14	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 05/2011
14	Disease Progression 10/2023 - 04/2015
14	Prostatic Neoplasms (Prostate Cancer) 05/2023 - 05/2010
13	Squamous Cell Carcinoma of Head and Neck 03/2024 - 05/2013
13	Renal Cell Carcinoma (Grawitz Tumor) 05/2023 - 05/2008
11	Carcinoma (Carcinomatosis) 01/2024 - 12/2002
9	Neutropenia 01/2023 - 04/2014
9	Anaplastic Thyroid Carcinoma 01/2022 - 10/2013
7	Osteoporosis 05/2023 - 05/2010
7	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2016
6	Bone Resorption 03/2013 - 01/2003
5	Anorexia 01/2023 - 11/2011
5	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 09/2012
5	Fatigue 03/2022 - 11/2011
5	Lymphoma (Lymphomas) 06/2021 - 01/2006
5	Diarrhea 01/2019 - 02/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2023 - 01/2020
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2023 - 08/2021
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 09/2005
4	Exanthema (Rash) 10/2022 - 01/2007
4	Febrile Neutropenia 01/2022 - 10/2015
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 05/2008
4	Infections 01/2021 - 10/2008
4	Nausea 10/2017 - 01/2007
3	Drug-Related Side Effects and Adverse Reactions 02/2024 - 01/2020
3	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2017
3	Pain (Aches) 10/2022 - 01/2010
3	Neuroendocrine Carcinoma 05/2022 - 05/2005
3	medullary Thyroid cancer 01/2020 - 02/2017

Drug/Important Bio-Agent (IBA)

23	lenvatinibIBA 04/2024 - 12/2015
15	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 05/2005
15	Docetaxel (Taxotere)FDA Link 08/2019 - 04/2003
13	TrabectedinIBA 01/2023 - 04/2015
12	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2003
12	Hormones (Hormone)IBA 10/2023 - 04/2009
12	eribulin FDA Link 01/2023 - 01/2016
11	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2004
10	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2014
10	Trastuzumab (Herceptin)FDA Link 09/2023 - 01/2004
10	pazopanib FDA Link 01/2023 - 05/2015
10	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2007
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2004
10	NivolumabIBA 01/2022 - 10/2017
9	Immune Checkpoint InhibitorsIBA 03/2024 - 04/2020
9	Phosphotransferases (Kinase)IBA 01/2023 - 01/2007
9	AnthracyclinesIBA 07/2016 - 01/2009
8	PlatinumIBA 01/2023 - 05/2013
8	Capecitabine (Xeloda)FDA Link 01/2016 - 03/2007
7	trastuzumab deruxtecanIBA 01/2024 - 01/2019
7	Diphosphonates (Bisphosphonates)IBA 05/2023 - 01/2003
7	Aromatase InhibitorsIBA 05/2023 - 03/2011
7	Denosumab FDA Link 05/2023 - 01/2012
7	taxaneIBA 07/2016 - 02/2010
6	IodineIBA 04/2024 - 01/2017
6	Fluorouracil (Carac)FDA LinkGeneric 09/2023 - 01/2006
6	AndrogensIBA 05/2023 - 05/2010
6	pembrolizumabIBA 01/2023 - 01/2020
6	Cetuximab (Erbitux)FDA Link 12/2022 - 05/2013
6	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 04/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021 - 01/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 05/2008
6	Sunitinib (Sutent)FDA Link 03/2018 - 04/2011
6	Rituximab (Mabthera)FDA Link 08/2010 - 01/2006
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2024 - 10/2016
5	Monoclonal AntibodiesIBA 04/2020 - 06/2015
5	Phenobarbital (Luminal)FDA Link 01/2018 - 03/2014
4	Circulating Tumor DNAIBA 03/2024 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 04/2023 - 04/2009
4	RNA (Ribonucleic Acid)IBA 04/2023 - 01/2008
4	Tumor Biomarkers (Tumor Markers)IBA 05/2022 - 04/2006
4	CytokinesIBA 01/2021 - 01/2012
4	C-Reactive ProteinIBA 01/2021 - 01/2013
4	Zoledronic Acid (Zometa)FDA Link 10/2013 - 01/2012
4	Collagen Type I (Type I Collagen)IBA 03/2013 - 09/2003
3	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 09/2016
3	LigandsIBA 10/2022 - 03/2018
3	Estrogen ReceptorsIBA 05/2022 - 03/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 10/2013
3	Vincristine (Oncovin)FDA LinkGeneric 06/2021 - 05/2008
3	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 01/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 09/2019
3	AntibodiesIBA 01/2021 - 01/2006

Therapy/Procedure

79	Therapeutics 04/2024 - 02/2002
73	Drug Therapy (Chemotherapy) 09/2023 - 04/2003
9	Combination Drug Therapy (Combination Chemotherapy) 09/2016 - 01/2004
8	Castration 04/2021 - 02/2011
7	Neoadjuvant Therapy 01/2021 - 02/2010
6	Radiotherapy 09/2023 - 09/2005
5	Drug Tapering 01/2022 - 02/2002
4	Time-to-Treatment 01/2020 - 04/2009
3	Chemoradiotherapy 01/2023 - 02/2016
3	Induction Chemotherapy 02/2021 - 01/2019
3	Immunotherapy 09/2020 - 01/2013
3	Salvage Therapy 04/2020 - 02/2002